Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A phase IV, randomized, open-label, controlled, post-licensure study to evaluate the safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (Cervarix®) when administered intramuscularly according to a 0, 1, 6-month schedule in females aged 18-25 years https://www.kusajili.com:443/Trial/jsp9cGhY60G5jtMRLjk9gg%24a-phase-iv-randomized-open-label-controlled-post-licensure-study-to-evaluate-the-safety-of-glaxosmithkline-biologicals-hpv-1618
I have read and accept the terms of use of the site and the Privacy Policy
Send your message